|
108 |
A STUDY ON ADVERSE DRUG REACTIONS IN TWO REGIMENS
OF SHORT COURSE CHEMOTHERAPY |
Sudha Xirasagar, P Jagota, N Parimala & K Chaudhuri:
NTI Newsletter 1989, 25, 51-60. |
In a study of feasibility of treatment of smear
positive patients with Short Course Chemotherapy (SCC) regimens
under District TB Programme (DTP) conditions in a city, adverse
drug reactions in terms of frequency of episodes, incidence in the
cohort of patients, time of occurrence, major adverse reactions
requiring modification of chemotherapy and or symptomatic treatment,
were investigated.
Patients were allocated to one of the two 8 month
SCC regimens i.e., Regimen 'A' 1 SHRZ/6TH, Regimen 'B' 2SHR/6TH.
Overall incidence of adverse drug reaction in cohort of 265 patients
was 37%, 9% of which were considered as major in nature. 34 episodes
of such reactions resulted in modification of chemotherapy in 15
patients during intensive phase. Though gastro intestinal symptoms
were predominant, cutaneous toxicity was the pre eminent cause of
modification of regimen. No case of exfoliative dermatitis occurred.
A total of 333 episodes of adverse drug reactions of minor nature
occurred; 50% being gastro intestinal symptoms followed by cutaneous
symptoms. More than 70% of all adverse drug reactions of intensive
phase occurred in the first half of the period. There was no significant
difference between the two regimens in the incidence of adverse
drug reactions of either major or minor in nature.
SCC is being implemented in a phased manner in
the DTP. Before introducing SCC in large number of districts, it
would be prudent to find out whether SCC would be acceptable to
both doctor and patient in terms of adverse drug reactions.
It can, therefore, be concluded that adverse reactions may not be
a major constraint for inclusion of SCC under DTP for treating sputum
positive tuberculosis patients provided that additional resources
and man power are allocated to the DTCs to manage patients in the
centre and extend effective guidance to staff working in peripheral
centres.
|
KEY WORDS: SCC REGIMEN, DAILY REGIMEN, ADVERSE
REACTIONS, CONTROL PROGRAMME, FEASIBILITY. |
110 |
A STUDY OF OPERATIONAL FACTORS INFLUENCING THE APPLICABILITY
OF TWO REGIMENS OF SHORT COURSE CHEMOTHERAPY UNDER CONDITIONS OF AN
URBAN TUBERCULOSIS PROGRAMME |
P Jagota, Sudha Xirasagar, N Parimala & K Chaudhuri:
Indian J TB 1989, 36, 213-23. |
An operational study of two regimens of Short Course
Chemotherapy (SCC) to assess their efficacy under programme conditions,
applicability and feasibility in District TB Programme (DTP) was
undertaken in an urban TB centre. The two regimens studied were
1SHRZ/7TH and 2SHR/6TH. Their operational efficacy (efficiency)
was found to be 87% and 92% respectively which had already been
reported in an earlier paper. The various factors i.e., initial
willingness, drug default, treatment completion pattern, adverse
drug reactions and initial drug resistance with their potential
harmful effects on the treatment outcome as well as work load and
extra cost these regimens entail for DTP organisation are discussed
in this paper.
Out of a total of 1822 smear positive patients
diagnosed at the Lady Willingdon State TB Centre during intake period
(Feb '84 to March '85), 1126 were residents of Bangalore City. Of
these 695 (61.7%) were unwilling to attend the clinic daily for
2 months, 27 were unfit and one was excluded by mistake. Thus, 403
(38.3%) initially willing patients were classified either as 'core
group' or 'Non core group, according to the history of previous
anti TB treatment (321 and 82 respectively). Of the 695 (77.6%)
unwilling persons, majority were those who pleaded inability to
attend daily for 2 months without specifying any particular reason.
Refusal of SCC due to injections accounted for 12.8% and 9.5% wanted
to take treatment elsewhere. Old age influenced willingness adversely.
Of the 321 patients in the core group, 56 were
excluded due to missing more than 50% of intensive phase doses.
Among the remaining patients, 61 (48%) out of 127 patients on Regimen
A and 48 (34%) out of 138 on Regimen B, did not make a single default
in the intensive phase. Of the total 910 defaults for which actions
were taken, 640 (70%) were retrieved by letter writing,
among the remaining 293 (72%) were retrieved by home visiting.
Main reasons for default elicited during home visits were: going
out of station (52.9%) followed by patients being busy with work
(19.1%). Compensatory phase was availed by 156 of the 265 patients
who missed one or more doses due to default in the treatment. The
pattern of treatment completion of 321 core group patients in the
two regimens were similar i.e., in both the phases 65% for Regimen
A and 63% for Regimen B. Incidence of minor adverse reactions was
28% and major toxic reactions were experienced by 8.4% of patients.
Workload for treating 321 patients was due to supervised administration
of drug 45 patients per day. Letter writing to 3.1 per patients,
home visiting 1.1 per patient and doctor's attention for adverse
reaction 2 occasions per patient. This could be managed with the
existing staff. The cost of Regimen A was Rs.220/ per patient and
for Regimen B, 268/ per patient. Cost to patient for transportation
was Rs.70/ and Rs.113/ for Regimen A and B respectively.The major
disturbing finding of the study was initial low acceptability of
about 40% for SCC. The home visiting which was crucial in increasing
the completion rate in this study is usually not available in most
of the DTCs. Workload, adverse reactions etc. were not of any problem
for implementation of SCC in the programme.
|
KEY WORDS: SCC, DAILY REGIMEN, OPERATIONAL FACTORS,
APPLICABILITY, CONTROL PROGRAMME. |
111 |
THE FATE OF RESISTANT CASES TREATED WITH THREE DIFFERENT
DRUG REGIMENS OF SHORT COURSE CHEMOTHERAPY UNDER PROGRAMME CONDITIONS |
P Jagota, TR Sreenivas, N Parimala & K Chaudhuri:
Indian J TB 1990, 37, 83-87. |
The fate of patients with isoniazid (H) resistant
pulmonary tuberculosis, treated with 3 different Short Course Chemotherapy
regimens (Regimen A-1 SHRZ/7TH, Regimen B-2SHR/6TH, Regimen C-2EHR/4H2R2)
was examined in two sequential studies. One hundred H resistant
patients belonging to two groups-one without history of previous
treatment(core group) and second with history of previous treatment
>=15 days (non-core group), were followed up at the end of 12th,
15th and 24th/36th month of chemotherapy. Bacteriological favourable
response among patients in the core group at the end of chemotherapy
with Regimen A, B and C were 65.2% of 23 patients, 50% of l8 patients,
and 57.1% of 18 patients respectively. The response among patients
in the non-core group were 27.3% with Regimen A and 52.6% with Regimen
B.
At the end of 24/36th month of chemotherapy, 62.5%
patients in the core group and 2 out of 7 in the non-core group
on regimen A and 68.7% patients on regimen C in the core group and
5 out of 15 in the core group and 41.7% in the non-core group on
regimen B were culture negative. The relapses were significantly
high in regimen B & C in comparison with regimen A. Thus, of
the total 100 patients, 99.3% were eligible for examination (1 died
during chemotherapy), 67 were examined and of them 37 (62.7%) were
culture negative, 22 positive and 8 were dead. The development of
drug resistance to rifampicin was directly related to the duration
of its use.
|
KEY WORDS: SCC, DRUG RESISTANCE, EFFICACY, CONTROL
PROGRAMME, FATE. |
113 |
IMPACT OF SHORT COURSE CHEMOTHERAPY ON THE OPERATIONAL
EFFICIENCY OF NATIONAL TUBERCULOSIS PROGRAMME |
TR Sreenivas, CV Shyamasundara, K Chaudhuri: Indian
J TB 1992, 39, 107-11. |
Five districts in which short course chemotherapy
(SCC) was introduced during 1987-88 (DTP-SCC) and an equal number
of districts without an SCC programme (DTP-SR) but having comparable
new sputum examinations performance (NSE) in 1986 were selected
from the states of Gujarat and Tamilnadu. Data obtained by the monitoring
cell of the National Tuberculosis Institute (NTI) for 15 consecutive
quarters from the lst quarter of 1986 were analysed. It was possible
to study operational variables: NSE, number of pulmonary patients
diagnosed (TBP) and number of bacillary cases detected (BCASE).
While the figures of first six quarters were used to represent pre
SCC performance, those of the last six quarters depicted the post
SCC scenario. However, the trend analysis has been done using the
whole data.
The growth rates of NSE, TBP and BCASE were 14.1%,
1.7% and 13.0% respectively for DTP-SCC compared with 17.0%, 5.3%
and 29% for DTP-SR. Both the DTCs and PHIs in DTP-SR showed negative
growth in BCASE, inspite of their efforts as evidenced by increase
in NSE and TBP, the introduction of SCC led to an increase in BCASE
for both DTC and PHIs. While the PHIs in DTP-SCC showed increased
efficiency in all the aspects (NSE 24.4%, TBP 19%, BCASE 16.7%),
DTCs showed decreased activity in NSE ( -2.4) and TBP (-6.6%), indicating
improvement at the periphery. Trend analysis corroborated the above
findings.
|
KEY WORDS: SCC, IMPACT, OPERATIONAL EFFICACY,
CONTROL PROGRAMME. |
114 |
INITIAL DRUG RESISTANCE TO ANTI TUBERCULOSIS DRUGS
IN URBAN AND RURAL DISTRICT TUBERCULOSIS PROGRAMME |
Sujatha Chandrasekaran, P Jagota, & K Chaudhuri:
Indian J TB 1992, 39, 171-75. |
The problem of drug resistance in tuberculosis
is said to be on the increase in developing countries. This could
adversely affect control measures. A knowledge of the prevalence
and pattern of drug resistance would be of great help to the programme
planners for purposes of monitoring and future planning. Hence,
a survey on initial drug resistance to anti-TB drugs, as it occurs
under programme conditions, was conducted in the urban situation
of Bangalore and rural area of Kolar district. The proportion of
Initial Drug Resistance (IDR) to anti tuberculosis drugs was estimated
among new patients attending Bangalore (urban) and Kolar (rural)
District Tuberculosis Programmes (DTPs). The sputum samples were
collected from all newly diagnosed patients in this area and subjected
for culture and drug sensitivity tests. It was observed that IDR
to any drug was 34.9% (Isoniazid 32.87% and Rifampicin 4.4%) among
Kolar patients. Among Bangalore patients, IDR was 20.57% (Isoniazid
17.35% and Rifampicin 2.89%). Combined resistance to isoniazid and
rifampicin was 1.36% in urban DTC and 3.42% in rural DTP. With the
introduction of Short Course Chemotherapy in DTP, combined resistance
to isoniazid and rifampicin assumes paramount importance and needs
to be monitored continuously.
|
KEY WORDS: INITIAL DRUG RESISTANCE. |
115 |
RESULTS OF TREATMENT WITH A SHORT COURSE CHEMOTHERAPY
REGIMEN USED UNDER FIELD CONDITIONS IN DISTRICT TUBERCULOSIS PROGRAMME |
K Chaudhuri, P Jagota & N Parimala: Indian J
TB 1993, 40, 83-89. |
The treatment results of an unsupervised Short
Course Chemotherapy (SCC) regimen used under conditions of District
Tuberculosis Programme (DTP) are presented. The District Tuberculosis
Centre (DTC), Kolar and six of its Peripheral Health Institutions
(PHIs) formed the study area. No extra efforts except ensuring of
adequate availability of drugs at the participating centres were
made to obtain patients' compliance. In all, 584 smear positive
tuberculosis patients were diagnosed during the study period but
28.3% of the patients could not be initiated on treatment with the
chosen self administered SCC regimen -2EHRZ/6TH(EH).
Of the 382 put on treatment, only 33.2% completed
over 75% drug collections in both intensive and continuation phases.
The pattern of treatment compliance did not vary with the place
of treatment, i.e. DTC or PHI. Irrespective of treatment compliance,
nearly 72-77% of the patients attained smear negative status at
the end of the period of treatment, there being no difference between
PHI and DTC. However, deaths were higher in the PHI patients. This
could be attributed to a significantly higher proportion of aged
patients taking treatment at PHI than at DTC. Considering death
as an unfavourable outcome, overall favourable response was 65.9%.
Patients with drug sensitive bacilli had a higher rate of culture
negativity (70%), as compared to those with drug resistant bacilli
(48%). It was concluded that unsupervised SCC could give encouraging
results in a DTP setting, provided adequate drug supply was ensured.
|
KEY WORDS: SCC, CONTROL PROGRAMME, OPERATIONAL
EFFICACY. |
|
|